Search by Drug Name or NDC
NDC 42508-0210-09 Clear Future Intensive Spot Treatment 2 mg/15mL Details
Clear Future Intensive Spot Treatment 2 mg/15mL
Clear Future Intensive Spot Treatment is a TOPICAL LOTION in the HUMAN OTC DRUG category. It is labeled and distributed by Arbonne International, LLC. The primary component is SALICYLIC ACID.
Product Information
| NDC | 42508-0210 |
|---|---|
| Product ID | 42508-210_e8686689-1d7d-4d87-8187-0cd6de346e2d |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Clear Future Intensive Spot Treatment |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | SALICYLIC ACID |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | LOTION |
| Route | TOPICAL |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | mg/15mL |
| Substance Name | SALICYLIC ACID |
| Labeler Name | Arbonne International, LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part333D |
| Listing Certified Through | 2024-12-31 |
Package
NDC 42508-0210-09 (42508021009)
| NDC Package Code | 42508-210-09 |
|---|---|
| Billing NDC | 42508021009 |
| Package | 1 TUBE in 1 CARTON (42508-210-09) / 15 mL in 1 TUBE |
| Marketing Start Date | 2015-04-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |